Oncolytic virotherapy is an official, innovative and effective cancer treatment using a special virus, which is capable of finding and destroying cells of a malignant tumour in human body. Medicinal product is intramuscularly injected in a body. To learn more about virotherapy see here:

Virotherapy takes place on in-patient or out-patient basis, depending on situation and patient’s health condition. Treatment takes place pursuant to tailor-made treatment protocol and in accordance with the application guidelines under the supervision of the doctor. Average treatment period is 3 years during which a regular monitoring of analyses and patient observation takes place.

Cancer virotherapy is a treatment method that is gentle to a body and has minimum side effects. Most common side effect is slightly increased body temperature (up to 37.5°C, 99.5°F) lasting one to three days.


The Virotherapy can practice only doctors who has completed the educational course and are certified to practice virotherapy and prescribe virotherapy medication.

Oncolytic Virotherapy with Riga virus is available worldwide and is practiced by:

  • Virotherapy Excellence center with fully integrated virotherapy programs and virotherapy as core treatment program

  • virotherapy partner and science clinics with extensive experience and knowledge base, which has proved their use of the correct guidelines in the long run

The Virotherapy is practiced by:

  • more than 20 accredited clinics

  • more than 200 certified doctors from more than 25 countries

If you wish to find out more about possibilities of virotherapy treatment in your particular case, to find the closest virotherapy delivery location, to learn more about the treatment process or other related issues, please, contact the Patient Information Center

Where to start?

  • Patient contacts in virotherapy certified doctor or accredited clinic specialising. IVC information Centre will assist patient to allocate the doctor or clinic. Contact IVC information Centre here:

  • Patient makes the necessary analyses and sends the results to the doctor for the eligibility assessment.

  • After reading patient's medical history and analyses, the doctor provides a recommendation regarding a possibility to use virotherapy.

  • If the virotherapy is possible, an individual treatment schedule is elaborated, matching the patient's immunity condition, type of cancer, localisation and tumour stage.

  • The treatment agreement with the clinic or doctor is signed.

  • The virotherapy course of treatment is commenced – a patient receives first medication injections.

  • Frequency of medication injections usually decreases during the course of treatment.

  • Regular monitoring of analyses and patient observation take place.

  • Treatment schedule can be corrected depending on the results of analyses.

← Go back

Application form

Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE

+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)

© 2017 International Virotherapy Center Limited. All Rights Reserved